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Abstract
A protocol is described using lipid mutants and thiol-specific chemical reagents to study lipid-
dependent and host-specific membrane protein topogenesis by the substituted-cysteine
accessibility method as applied to transmembrane domains (SCAMTM). SCAMTM is adapted to
follow changes in membrane protein topology as a function of changes in membrane lipid
composition. The strategy described can be adapted to any membrane system.
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1 Introduction
Membrane proteins represent at least 30% of the all currently sequenced genomes and
represent more than half the drug targets pursued by pharmaceutical companies (1).
Effective drug design is dependent on understanding membrane protein structure and the
rules that govern the folding and assembly of native and mutant membrane proteins. A
fundamental aspect of the structure of polytopic membrane proteins is membrane protein
topology. Membrane protein topology describes the way a polypeptide chain is arranged in
the membrane, i.e. the number of transmembrane domains (TMs) and their orientation in the
membrane. Final protein topology is determined by topogenic signals in the nascent
polypeptide chain that are recognized and decoded not only by the protein insertion
machinery (2) but by the lipid profile (3–9).
Although the methodology for obtaining high-resolution structures for membrane proteins is
improving, the need to determine low-resolution organizational information on membrane
proteins in a native membrane continues. Given the enormous number of sequences that are
available in genome-sequencing projects, it is not realistic to assume that the structures of all
the encoded proteins will be generated by crystallographic approaches, especially for
membrane proteins. Moreover purification, crystallization and structure determination of
membrane proteins still remain a challenge. Crystal structures are static and may be
distorted due to purification and crystallization constraints. Information on interactions with
other proteins and the lipid environment are also lost during purification. During protein
purification, molecular interactions with lipids are replaced by non-native detergent
interactions. Heterologous expression in a host strain with a different lipid composition than
the native host can also result in loss of proper lipid-protein interactions, which can affect
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topological organization and function. Therefore, non-crystallographic approaches have
been developed to determine lower resolution topological arrangement of membrane
spanning segments in whole proteins as a function of membrane lipid composition (3, 6, 8).
Dynamic aspects of protein structure as a function of the physiological state of the cell is
best probed in whole cells or membranes. Escherichia coli strains genetically altered in their
lipid composition (10) (Fig. 1) and thiol-specific chemical reagents have been developed to
study lipid-dependent and host-specific membrane protein topogenesis by the substituted-
cysteine accessibility method as applied to TMs (SCAMTM) (3, 5–8). In this approach
cysteine residues replace individual amino acids that reside in the putative extracellular or
intracellular loops connecting TMs of a membrane protein expressed in a strain in which
lipid composition can be changed either before (3, 8) or after (3, 5, 9) membrane protein
synthesis and assembly. Combining of these techniques provides a system in which to study
the role of lipid-protein interactions in determining the structure, assembly and function of
membrane proteins. By combining SCAMTM with mutants of E. coli in which membrane
phospholipid composition can be systematically controlled, the role of phospholipids as
determinants of membrane protein topological organization was established (3, 8, 9). In
addition, the ability to change lipid composition post-assembly of a membrane protein
demonstrated the potential for polytopic membrane proteins to change their topological
organization after insertion and assembly in the membrane (3, 5, 9).
The following protocol describes (1) preparation of derivatives of the target protein, (2)
description and use of hosts with varied lipid composition and (3) use of SCAMTM to map
the topological organization of the target protein.
2 Materials
2.1 Transformation Protocol
1. 10X RbCl/CaCl2 Transformation Salts for the preparation of transformation
competent bacterial cells (MP Biomedicals, USA).
2. Centrifuge 5417R (Eppendorf).
2.2 Growth of E. coli Strains
1. Luria–Bertani (LB) medium.
2. 2.5 M MgCl2.
3. Ampicillin (amp) (100 mg/ml).
4. 500 mM isopropyl-β-D-thiogalactoside (IPTG).
5. Anhydrotetracycline (aTc) (Spectrum) (10 mg/ml).
2.3 SCAMTM
1. Buffer A: 100 mM HEPES/KOH buffer, 250 mM sucrose, 25 mM MgCl2, 0.1 mM
KCl, adjusted to pH 7 or 10.5.
2. 10 mM 3-(N-maleimidylpropionyl) biocytin (MPB) (Invitrogen-Molecular Probes)
freshly dissolved in dimethyl sulfoxide (DMSO).
3. 2 M β-mercaptoethanol.
4. Digital Sonifier (Branson, USA).
5. Beckman Coulter TLA-100 ultracentrifuge equipped with TLA-55 rotor.
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6. Microfuge Polyallomer Tubes (natural tint, capacity 1.5 ml) (Beckman Coulter).
7. Centrifuge 5417R (Eppendorf).
2.4 Membrane Protein Solubilization Buffer
1. Solubilization buffer: 50 mM Tris-HCl buffer (pH 8.1) 2% SDS, 1 mM EDTA.
2. Fisher Vortex Genie 2 equipped with microtube foam rack for multiple polyallomer
tubes (Fisher Scientific).
2.5 SDS-PAGE
1. 2X SDS gel loading (sample) buffer: 10 mM Tris-HCl (pH 6.8), 5.6% SDS, 200
mM dithiothreitol, 10% glycerol, 0.01% bromophenol blue.
2. READY GEL: Tris-HCl precast gel for SDS Polyacrylamide Electrophoresis,
12.5% polyacrylamide (BIO-RAD Laboratories).
2.6 Immunoprecipitation (IP) buffer
1. 50 mM Tris-HCl (pH 8.1), 0.15 M NaCl, 2% Lubrol-PX, 0.4% SDS, 1 mM EDTA
(see note 1).
2.7 Immunoblot Analysis (Western Blotting)
1. 0.45 μm Protran BA 85 Nitrocellulose transfer membranes (Whatman-Schlicher
and Schuell)
2. Blocking buffer: 5% bovine serum albumin (BSA) (Fraction V, heat-shock treated)
(Fisher Scientific) in Tris Buffered Saline (TBS) (10 mM Tris-HCl, pH 7.4, 0.9 %
NaCl).
3. ImmunoPureR Avidin Horseradish Peroxidase (Avidin-HRP): Avidin linked to
horse radish peroxidase (reconstituted to concentration of 2 mg/ml according
manufacture suggestion) (Thermo Scientific).
4. SuperSignal West Pico chemiluminescent substrates for detection of HRP (Thermo
Scientific).
5. Labconco Semi-Dry blotting system (W.E.P, Company Seattle, Washington, USA).
6. Anode buffer No.1: 0.3 M Tris (pH 10.4) in 10% methanol.
7. Anode buffer No. 2: 25 mM Tris (pH 10.4) in 10% methanol.
8. Cathode buffer: 25 mM Tris, 40mM glycine (pH 9.4) in 20% methanol.
9. Wash Buffer: 10 mM Tris-HCl (pH 7.4), 0.9 % NaCl containing, 0.05% Nonidet
P40 (Igepal TM CA-630) (USB Corporation, Cleveland, OH, USA).
10. Chromatography Paper: 3 mm Cr (Whatman).
2.8 Alkali Treatment Solution
1. 0.2 N NaOH.
2. Beckman Coulter TLA-100 ultracentrifuge equipped with TLA-55 rotor.
1Pre-chilled (+4°C) 50 mM Tris-HCl (pH 8.1) should be used to prepare IP buffer with SDS/non-ionic detergent ratio 1/5.
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2.9 Image Acquisition and Data Processing
1. Fluor-S MaxTM MultiImager (Bio-Rad) equipped with a CCD camera and a Nikon
50mm 1:1.4 AD (F 1.4) lens at the ultrasensitive chemiluminescence setting which
cools the camera to −33°C.
3 Methods
3.1 Lipid Mutants as Biological Reagents
The ability to regulate membrane lipid composition under steady state conditions (10) (Fig.
1a) coupled with determination of membrane protein orientation with respect to the plane of
the membrane bilayer is a powerful approach to establish membrane protein topology or
observe changes in topology as a function of membrane lipid environment (3, 8, 9) and the
amino acid sequence of membrane proteins (5). The utilization of strains in which lipid
composition is under control of a tightly inducible promoter (Fig. 1b) reveals surprising
topological dynamics of a polypeptide after stable membrane insertion (3, 5, 9).
3.2 SCAMTM
This approach is based on introduction of cysteine residues one at a time into putative
extracellular or intracellular loops of a cysteine-less membrane protein of interest followed
by chemical modification with a membrane impermeable thiol-specific probe either before
or after compromising cell membrane integrity to determine cysteine membrane sidedness.
Accessibility in whole cells establishes extracellular location while accessibility only after
cell disruption establishes intracellular location (see notes 6, 7 and 9). The accessibility of
extramembrane domains flanking a TM then establishes orientation of the TM with respect
to the plane of the membrane bilayer (6).
3.2.1 Construction of Plasmids Expressing Single Cysteine Derivatives—
Cysteine is a relatively hydrophobic, small amino acid, and its introduction at most positions
in a membrane protein is likely to be tolerated. Furthermore, cysteine has little preference
6Caution must be used in assigning an intramembrane location to a cysteine residue because it is unreactive to hydrophilic thiol
reagent in both intact and disrupted cells. Lack of or low levels of labeling may result from any of the following reasons: (1) steric
hindrance due to local secondary structure; (2) internalization into the compact fold of the protein; (3) lack of ionization of the thiol
group due to a hydrophobic environment; (4) local environment with the same charge as the thiol reagent; (5) increased pKa of the
thiol due to the high negative charge density of neighboring residues or anionic lipids; (6) facing other helices. Periplasmic
extramembrane domains tend to be shorter (sometimes only three amino acids in length) than cytoplasmic domains. Therefore, there
may be little or no protrusion of these loops into the extracellular space, thus preventing reaction of the cysteine residues in these
locations with relatively bulky reagents. Alkylating reagents appear to react better with cysteines towards the middle of extended
hydrophilic loops than near the TM interfacial domain. Cysteine scanning across a domain is an effective means for identifying useful
replacement sites and differentiating between local effects and true TMs. Scanning can be coupled with alkaline treatment as
discussed above. Finally, reagents of different size and charge can be tested (6).
7Conclusions based on full reactivity of diagnostic residues should be made with caution, since cysteine residues facing a hydrophilic
pore or near a substrate-binding site maybe within a TM segment but chemically reactive due to water channels or pockets. Therefore
an extramembrane domain and an aqueous pore are not easily distinguished by SCAMTM. Substitution at positions crucial to overall
protein structure and stability cannot be used, but such substitutions often result in low levels of the protein or loss of activity and are
informative.
9TM topology studies assume that all copies of the target protein have the same orientation. The labeling patterns are the result of end-
point titrations and assume a relatively fixed conformation for extramembrane loops, ignoring the presence of regions with heightened
mobility and flexibility or the possibility of topological inversions on the time scale of the labeling. Topological models derived from
accessibility patterns depict a static TM topology whereas the actual structure in a membrane is more likely to be dynamic. Through
the application of SCAMTM some examples exist of dynamic changes in topological organization induced post-assembly of
membrane proteins as well as some proteins that appear to exist with multiple topological organizations (6). Even with optimal assays
and reagents, membrane proteins that assume multiple conformations either within the same or between different membranes may
yield confusing and conflicting results. Therefore, the static nature of methods that measure topological organization may have missed
more dynamic properties of membrane proteins. In particular low yield of modification due to slow rate of reaction may be due to
dynamic movement of a domain into and out of an accessible region. There are examples of cryptic intramembrane regions that
become exposed to the aqueous phase and extramembrane domains that translocate to the opposite side of the membrane which limit
topology studies in intact cells where the protein is turning over or metabolic conditions influence organization (6).
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for a particular secondary structure. As an example an AmpR plasmid encoding a derivative
of LacY (lactose permease of E. coli) in which endogenous cysteines are replaced by serine
or alanine (cysteine-less LacY) is constructed using the site-directed mutagenesis
Quickchange XL kit from Stratagene (11). Using the same method single cysteine
replacements of amino acids in putative extramembrane domains are constructed (5, 8, 12).
All amino acid substitutions are verified by DNA sequencing. Functional analysis and
expression level by Western blotting of each derivative should be carried out if possible.
Ideally gene expression should be under control of an inducible promoter such as OPtac to
minimize continuous expression of potentially disruptive gene products especial in an
altered lipid environment.
The process of choosing suitable residues for replacement by cysteine is often empirically
determined, and the rationale for deciding which residues to alter is aided by the following
considerations. Secondary structure predicted by computer-aided hydropathy analysis
(reviewed (13) and thus far 60–70% reliable) is an initial starting point for the likelihood
that a particular residue is in an extramembrane domain. The native cysteine residues are
usually changed into alanine or serine residues which are small, commonly found in
membrane proteins and appear to be tolerated at most positions thus rendering an active
protein. Replacement of charged residues is generally not advised because these have a high
probability of being topogenic signals or may be involved in long-range interactions.
Consideration should be given to whether the replacement will be well-tolerated based on
structural and functional information about the protein. Therefore, a prerequisite for each
cysteine replacement is retention of function that provides assurance of retention of near
native structure. If the protein contains stretches of residues of intermediate hydrophobicity
that cannot unambiguously be identified as membrane spanning, substitutions should be
made approximately every 10 residues. The cysteine-less protein serves as the starting
template for introducing single cysteine residues at desired positions as well as a negative
labeling control to assure that residues such as lysine and histidine are not labeled by the
reagents. Alternatively, templates containing natural cysteines can be utilized in this assay if
they do not react with the thiol-specific reagents due to steric hindrance or membrane
residency.
To obtain a minimal topological map a single cysteine replacement in each of the putative
extramembrane loops should be expressed from a plasmid and analyzed in a host with wild
type lipid composition. In practice, several cysteine replacements or complete cysteine
scanning across extramembrane loops and into TM segments is required for a more precise
mapping of topology. The host strain for plasmid expression should be deleted of the target
protein gene if it contains native cysteines and is expressed at levels high enough to be
detected in the assay. Since the target protein is expressed from a multicopy plasmid, it is
often possible to analyze a protein in its normal host without deletion of the native protein.
3.2.2 Transformation of Phosphatidylethanolamine-Deficient E. coli Cells with
Plasmids—Single cysteine replacements are expressed in the appropriate lipid host. The
transformability of an engineered E. coli strain (AL95) lacking its major nonbilayer-prone
and zwitterionic lipid phosphatidylethanolamine (PE, 75 mole% of total phospholipid) is
compromised by a requirement for divalent cations (10–50 mM Mg+2) for viability, cell
integrity, proper cell division, membrane impermeability and osmotic stress response (14–
17). Most of the above phenotypes are corrected by introduction of the “foreign” non-
bilayer-prone neutral glycolipids α-monoglucosyldiacylglycerol (MGlcDAG) or bilayer-
prone diglucosyldiacylglycerol (GlcGlcDAG, but increased passive membrane permeability
of the inner and outer membranes remains (17, 18). Therefore, variations of conventional
transformation protocols are required to make different lipid hosts competent for plasmid
DNA uptake. Electroporation, which requires suspension of cells in very low ionic strength
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media, cannot be used. In most cases cells can be made competent for transformation using a
RbCl/CaCl2-containing solution, which is suitable for strains with normal as well as altered
lipid compositions.
1 Dilute 0.1 ml of a fresh overnight culture of PE-lacking host cells grown in LB
medium with 50 mM MgCl2 into 5 ml of 37°C LB media supplemented with 50
mM MgCl2 to support growth in the absence of PE (15 ml tube). Cells lacking
PE must be kept in the presence of at least 20 mM MgCl2 or RbCl/CaCl2 during
all manipulations (see note 2). MgCl2 can be eliminated in the above procedure
for cells containing PE and more standard methods of transformation can be
used. Cells containing plasmid pDD72 (encodes wild type gene required for PE
synthesis) or its derivatives must be grown at 30 C because the plasmid is
temperature sensitive for replication.
2 Grow cells with vigorous aeration for 3–4 h until cells reach mid-log phase
(OD600 = 0.6).
3 Place 1 ml of culture into a sterile microfuge tube and incubate at 4°C for 30
min. Centrifuge in pre-chilled (+4°C) bench centrifuge 5417R (Eppendorf) at
14,000 rpm (20,800 x g) for 1 min to pellet cells and gently resuspend in 0.5 ml
of ice-cold 1X RbCl/CaCl2 Transformation Salts.
5 After 30 min on ice, centrifuge to pellet cells and gently resuspend in 0.1 ml of
ice-cold 1X RbCl/CaCl2 Transformation Salts. Keep cell suspension on ice.
6 Cells are now competent. Add plasmid DNA (100–200 ng) and incubate 30 min
on ice.
7 Heat shock for 2 min at 42 C and place on ice for 2 min. Add 1 ml LB
containing 50 mM MgCl2 and grow at 37°C for at least 2 hr.
8 Pellet the cells and resuspend in 50 μl LB containing 50 mM MgCl2 and plate
on LB agar plates containing 50 mM MgCl2 and 100 μg/ml of ampicillin. Plates
should be fresh or no more than a few days old for best results. Grow at least 2
days at 37 C. Individual colonies are streaked for single colonies on LB plates
containing ampicillin and either with or without MgCl2. Single colonies are
screened to verify MgCl2 dependence to eliminate potential contaiminants.
3.2.3 Cell growth and Regulated Expression of LacY and PssA Genes
1 Cells (see Fig 1a for strain description) carrying plasmids expressing single
cysteine replacements in cysteine-less LacY under OPtac control are grown for
at least two generations in LB medium supplemented with 50 mM MgCl2 to
support growth in the absence of PE (see note 2), ampicillin (100 μg/ml) to
maintain LacY plasmids, and IPTG (1 mM) to induce LacY expression.
2 To independently regulate expression of LacY and PE, strain AT2033 (PLtetO-1-
pssA+ pss93::kanR lacY::Tn9 recA srl::Tn10) is used. In this strain the level of
aTc in the growth medium regulates chromosomal pssA (encodes
phosphatidylserine synthase for PE synthesis) expression and PE content of the
cell. Expression of a plasmid copy of OPtac-lacY is regulated by IPTG. In order
to determine the effect of a change in membrane lipid composition on the
topological organization of LacY, cells are grown first in the presence of IPTG
2Cells lacking PE must not be exposed to solutions with MgCl2 concentrations less than 10 mM. However, when comparing cells
with different lipid compositions to wild type cells, the MgCl2 concentration should be the same for all samples and in the range of
10–50 mM with the higher concentration being optimal for growth of most PE-lacking strains.
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without aTc to allow synthesis and membrane insertion of LacY in the absence
of PE. Then cells are switched to growth without IPTG in presence of aTc in
order to permit biosynthesis of new PE in the absence of newly synthesized
LacY.
2.1 Cells of strain AT2033 containing different plasmids expressing derivatives of
LacY are first grown overnight at 37°C in LB medium supplemented with
ampicillin (100 μg/ml, required for plasmid maintenance) and 50 mM MgCl2 to
support growth at residual levels (ca. 2–3 mole%) of PE.
2.2 Then cells are diluted to OD600 of ca. 0.05 into 200 ml of medium supplemented
with ampicillin (100 μg/ml) and 50 mM MgCl2, and the expression of the LacY
derivatives are induced by growth in the presence of 1 mM IPTG for at least two
generations (OD600 reading 0.20).
2.3 One-half of the cell culture (100 ml) is pelleted by centrifugation (3,000 x g) and
stored on ice for LacY for SCAM TM analysis.
2.4 Remaining cells (100 ml) are pelleted by centrifugation and washed twice by
centrifugation with pre-warmed sterile LB medium supplemented with 50 mM
MgCl2 to remove IPTG and then re-suspended in 100 ml of pre-warmed
medium supplemented with ampicillin (100 μg/ml) and 50 mM MgCl2.
Expression of the pssA gene is induced by addition of aTc (1 μg/ml).
2.5 After 3 h of growth in the presence of inducer, cells are harvested and subjected
to SCAMTM analysis.
3.2.4 General Protocol for SCAMTM—The chemical nature of the reactive portion of a
labeling reagent should be highly reactive with and selective for thiol groups and form a
stable non-exchangeable or non-hydrolysable derivative. Maleimide-based thiol reagents,
which are available in a wide variety of forms, are particularly suited for SCAMTM (6).
Maleimide reacts with the ionized form of a thiol group (Fig. 2a), and this reaction requires
a water molecule as a proton acceptor. Maleimides are virtually unreactive until they
encounter an available thiol group. For most water-exposed cysteine residues in proteins,
pKa of the thiol of cysteine lies in the range of 8 to 9 and formation of cysteinyl thiolate
anions is optimum in aqueous rather in a non-polar environment where the pKa of the thiol
of cysteine is around 14. Therefore, the reaction rate of different sulfhydryls is controlled
primarily by their water exposure making the residues that reside in regions of TM helices
unfavorable for the generation of thiolate anions. Thus, the labeling characteristics of
intramembrane (unreactive) and extramembrane (reactive) cysteines should be consistent
with their localization either in a non-polar or polar environment, respectively (6). In most
cases the unreactive cysteine residues are located within the membrane hydrophobic core or
in a sterically hindered environment as described below.
SCAMTM using thiol-specific membrane–impermeable MPB (Fig 2b) has been extensively
used to probe the topological organization of LacY (3, 5, 6, 8), high affinity phenylalanine
permease (PheP) (9) and γ-aminobutyric acid permease (GabP) (19) as a function of
membrane lipid composition. In this assay sonication of cells is used to disrupt cell
membranes, making both periplasmic and cytoplasmic cysteines accessible to MPB,
whereas cysteines located within a TM domain are still protected from labeling (6).
Derivatization of cysteines in whole cells indicates periplasmic expose while derivatization
only during sonication indicates cytoplasmic exposure, since desintegration allows thiol-
specific reagent access to both sides of the membrane. It is important to note that the extent
of biotinylation should be the same before and after sonication for an extracellular cysteine.
If sonication results in an increase in biotinylation this may indicate a mixed topology.
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Although single cysteine replacements could affect protein structure and expression,
conclusions are based on comparison of the extent of labeling in whole cells and disrupted
cells for the same protein in two different lipid environments. This approach simplifies
interpretation of data obtained with a series of protein derivatives that may express at
different levels since conclusions about topology are based on relative reactivity of cysteines
in the same sample before and after cell disruption. Since sample pairs are analyzed on the
same Western blot, no signal intensity normalization is required and the results are not
dependent the expression level of the derivative. The level of expression of any given
derivative will affect the absolute intensity of labeling but not the ratio of the labeling
between the sample pairs.
1. Harvest 100 ml mid-log phase (OD600 ~ 0.4–0.6) cells (see note 2) expressing a
single cysteine derivative of LacY or protein of interest by centrifugation and
suspend cell pellets in 1.5 ml of buffer A (adjusted to pH 7, 9 or 10.5 as indicated).
Divide the sample into two equal aliquots (0.75 ml) in Microfuge polyallomer tubes
(Beckman). To increase the reactivity of diagnostic cysteine residues (particularly
those that might be in sterically hindered extramembrane domains), the reaction
with MPB is carried out at pH 9 or 10.5 (see note 8).
2. Treat one set of samples with MPB at a final concentration of 100 μM (7.5 μl of 10
mM stock solution) (see notes 3 and 4) for 5 min at room temperature to label
cysteines exposed to the periplasmic side of the inner membrane. Quench the
reaction by the addition of β-mercaptoethanol to 20 mM (7.5 μl of 2 M stock
solution). After labeling, cells are sonicated for 1 min using an amplitude of 15%.
3. To simultaneously label cysteines exposed to both sides of cell membrane, subject
the remaining sample to sonication for 1 min in the presence of MPB at a final
concentration of 100 μM. Incubate for 4 min at room temperature and quench the
reaction by the addition of β-mercaptoethanol to 20 mM.
4. All sonicated samples are centrifuged at 4°C at 38,000 rpm (65,000 x g) (TLA-55
Beckman Coulter rotor) for 10 min followed by resuspension in 100 μl of Buffer A
containing 20 mM β-mercaptoethanol by vortexing for 2 hr at room temperature
8Since the formation of cysteinyl thiolate anions is favored by increasing the solution pH (optimum pH 8.0–8.5), increasing the pH
during labeling should favor the reaction. However, maleimides are known to react with primary amines at pH values above 7.5.
Therefore, attempts to increase efficiency of labeling by raising the pH of the assay should be thoroughly controlled in order to ensure
that the modification is confined to cysteine. An effective control to rule out non-thiol modifications is to use a cysteine-less target
protein.
3Final concentration of DMSO used to dissolve MPB should never exceed 0.5%.
4SCAMTM is based on the controlled membrane permeability of sulfhydryl reagents. The results of SCAMTM are valid only if the
modifying reagent is thiol-specific and membrane impermeable, cells are intact and cell disruption does not expose sterically hindered
or water inaccessible cysteine residues (3, 5, 6). Various reagents including MPB will cross the membrane in a concentration, time and
temperature dependent manner and permeability varies with genetic background of the host cells. Therefore, conditions must be
empirically determined to minimize derivatization of intracellular cysteines. Cell lysis during a labeling experiment or during
manipulation of cells will also result in labeling of intracellular cysteines. Pre-blocking external cysteines with AMS before labeling
intact cells with MPB provides a means of estimating the degree of labeling due to low permeability under different experimental
conditions.
The membrane permeability of a thiol-specific labeling reagent can be tested and labeling conditions (concentration, time and
temperature) established by quantification of the degree of labeling of an abundant cytoplasmic protein that is rich in surface exposed
cysteine residues. In E. coli β-galactosidase is ideal for this purpose due to its content of cysteine, mobility in a region on SDS PAGE
devoid of other major proteins, availability of mutants lacking the enzyme as a control, and availability of antibody against β-
galactosidase (Sigma ImmunoChemicals). Other cytosolic bacterial markers such a glutathione or elongation factor Tu have been used
to access membrane permeability. Significant differences in the permeability of different host strains emphasize the need to screen
host strains for reagent permeability prior to initiating experiments (6–8).
Whole and disrupted cells are treated with various concentrations of reagent from 10 μM to 1 mM, at temperatures from 0 C to 25°C,
and for various lengths of time from 5 min to 1 h. In most cases low concentration of MPB (100 μM) and relatively short incubation
period (5 min) at room temperature favor biotinylation of extramembrane thiol groups. In this case a labeling experiment with both
intact cells and disrupted cells is carried out except that soluble proteins rather than the membrane fraction are retained for
immunoprecipitation with antibody against β-galactosidase followed Western blotting analysis.
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using a Fisher Vortex Genie 2. The membranes are solubilizated by detergent, and
the target protein is isolated by immunoprecipitation or affinity purification as
described below.
5. Following modification with MPB and isolation by immunoprecipitation, the target
protein is resolved by SDS PAGE, transferred to a solid support, and detected by
Western blotting using avidin linked to horse radish peroxidase. SuperSignal West
Pico chemiluminescent substrate (Thermo Scientific) is used to visualize
biotinylated proteins. Biotinylation of exposed cysteine residues of whole cells
(periplasmic exposure) or only during sonication (cytoplasmic exposure) is
detected using a Fluor-STM MultiImager (Bio-Rad).
3.2.5 Sample Solubilization—After labeling, isolated membranes are solubilized with
the appropriate detergent or detergent mixture such as SDS alone, Triton X-100 alone, SDS
and Triton-X-100, CHAPS, octylglucoside, deoxycholate, cholate and Tween 20, β-D-
dodecylmaltoside or nonidet P-40 and sodium deoxycholate (6). Conditions must be
empirically determined that yield a non-aggregated soluble target protein throughout the
remainder of the procedure. Many membrane proteins aggregate if boiled in SDS so that
solubilization should be done between 37 C and 55 C. LacY forms irreversible polydisperse
aggregates if solubilized by Triton X-100 alone. Therefore, a membrane-embedded LacY
sample (100 μl) is solubilized by addition of an equal volume of solubilization buffer
followed by vigorous vortexing for 15 min at room temperature, incubation at 37°C for 15
min, and an additional 15 min vortexing at room temperature. Prior to immunoprecipitation,
the sample is diluted with buffer containing non-ionic detergent to neutralize the denaturing
properties of SDS (as described below) and cleared by centrifugation in a pre-chilled (+4°C)
bench centrifuge 5417R (Eppendorf) at 14,000 rpm (20, 800 x g) for 10 min.
3.2.6 Isolation of Derivatized Target Protein—The thiol reagents react with cysteine
residues present in all other proteins in the membrane. Immunoprecipitation of the
membrane protein of interest or a rapid purification step is necessary to eliminate other
labeled proteins. A biotin-maleimide labeled protein can be recovered from cell lysates
directly with streptavidin-agarose beads (20) and can then be detected by western blotting
using a target-specific antibody. For immunoprecipitation of labeled protein from
solubilized samples, polyclonal and monoclonal antibodies have been widely utilized.
Antigen-antibody complexes can be isolated using precipitation with Pansorbin
(Staphylococcus aureus cells) (3), protein A agarose (21) or protein A or G Sepharose beads
(22, 23). If antibodies specific to the protein under study are not available, then epitope tags
such as His6 can be incorporated at the C-terminus of the target protein for either
immunoprecipitation or isolation by Ni2+ chelated affinity resin (3, 24, 25). Use of affinity
methods with His-tagged proteins and small-scale batch purification procedures is becoming
the method of choice since the labeled protein can be directly extracted from the resin with
SDS-containing buffers followed by SDS PAGE (26). Of course protein function or
topology should not be compromised by the presence of the tag. To allow appropriate
antibody interaction with solubilized protein, SDS should be diluted with appropriate non-
ionic detergent. In case of LacY, samples (200 μl from above) are diluted with 300 μl of
cold Immunoprecipitation buffer followed by empirically established immunoprecipitation
protocols (3).
Following modification and isolation, the target protein is resolved by SDS PAGE,
transferred to a solid support, and detected by western blotting or one of the following
techniques (6). Thiol reagents are available that contain a biotin group, a fluorescent group,
or a radiolabel allowing detection of labeled proteins by avidin linked to horse radish
peroxidase (avidin-HRP) and indirect chemilumiscence detection, fluorescence, or
Bogdanov et al. Page 9
Methods Mol Biol. Author manuscript; available in PMC 2011 May 21.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
autoradiography, respectively. Signals can be quantified using available imaging systems
and software.
3.2.6 SDS-PAGE—The final immunoprecipitates are solubilized in 30 μl of SDS sample
buffer (10 mM Tris HCl (pH 6.8), 5.6% SDS, 200 mM DTT, 10% glycerol, 0.01%
bromophenol blue) by vigorous vortexing for 15 min at room temperature, incubation at
37°C for 15 min, and an additional 15 min vortexing at room temperature using a Fisher
Vortex Genie 2. Samples are subjected to SDS PAGE using standard protocols and then
transferred from the gel to a solid support by Western blotting.
3.2.7 Western Blot Analysis—Protein samples are transferred from the SDS
polyacrylamide gel to Protran BA 85 nitrocellulose membranes by electroblotting using a
semi-dry electroblotting system.
1. After electrophoresis, place the SDS-PAGE gel in the cathode buffer to equilibrate
for 10 min before blotting.
2. Cut out a piece of Protran BA 85 nitrocellulose transfer membrane and Whatman
filter papers sized to fit the SDS polyacrylamide gel. See Fig. 3, which shows the
procedure for building the blotting sandwich.
3. Soak the bottom layer of chromatography paper (Whatman 3 mm Cr) in Anode
buffer No.1 and allow excess buffer to drain from the paper. Place a drop of this
buffer in middle of positive electrode surface of the blotting apparatus, then lay
down the soaked filter paper. Center and smooth out by rolling with a glass tube to
establish good contact and eliminate air bubbles.
4. Place two layers of chromatography paper wetted with Anode buffer No. 2 on top
of paper soaked in Anode buffer No.1. Roll a glass tube over the chromatography
paper to smooth and remove trapped air bubbles.
5. Place a Protran BA 85 nitrocellulose transfer membrane wetted with distilled water
on top of the three layers of chromatography paper and roll with a glass tube.
6. Now center the acrylamide gel onto the transfer membrane makng sure that air
bubbles are not trapped in between the transfer membrane and acrylamide gel. Use
a glass tube dipped in Cathode buffer to gently roll out any trapped air.
7. Place three layers of chromatography paper soaked in Cathode buffer on top of the
acrylamide gel. Chromatography papers, gels and transfer membrane must be in the
same dimensions to achieve a uniform transfer.
8. Place the lid (negative electrode) over the trans-unit sandwich making sure that the
electrode rests on the sandwich.
9. Attach the power cables on Labconco Semi-Dry blotting system to a constant
voltage power supply capable of supplying sufficient current for transfer. Adjust
the power supply to provide initial current density of 2.5 mA/cm2 of gel area. The
voltage reading should be approximately 10 volts with new electrodes.
10. Transfer time is somewhat dependent on the size of the proteins and percentage of
gel used. In most cases complete transfer is achieved in 90 min.
3.2.8 Blocking Procedure—The nitrocellulose transfer membrane is then blocked
overnight with blocking buffer. Note that 0.05% Nonidet P-40 is omitted during blocking
prior to staining of biotinylated proteins with avidin-HRP.
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3.2.9. Staining with Avidin-HRP—MPB is a thiol reagent containing a biotin group,
which makes possible indirect chemilumiscence detection of labeled proteins after treatment
with avidin linked to horseradish peroxidase (avidin-HRP).
1. The nitrocellulose transfer membranes are washed once with TBS buffer containing
0.3% BSA for 10 min.
2. Avidin–HRP is added at a final dilution of 1: 5000–10,000 of 2 mg/ml stock
solution in TBS buffer containing 0.3% BSA and incubated for at least 1 h.
3. The sheets are washed two times with TBS buffer containing 0.3% BSA for 15 min
each followed by another two washes with TBS/Nonidet P40 buffer and once with
TBS buffer only.
4. To visualize biotinylated proteins, the sheets are incubated for 3 min with
SuperSignal West Pico chemiluminescent substrates (Thermo Scientific) mixed
immediately prior to use at a ratio of 1:1, and biotinylated proteins are visualized
using a Fluor-S MaxTM MultiImager (Bio-Rad).
3.2.10 Image Acquisition and Processing—Western blots are imaged using a Fluor-S
MaxTM MultiImager (Bio-Rad). Bio-Rad software Quantity OneTM versions 4.6.5.094 and
4.4.1 are used to collect and store the images as TIFF files, which can be imported later into
Adobe Illustrator to construct figures. Images are expanded or reduced so that the horizontal
strip containing the target protein images is sized appropriately and masked to only show the
target protein results, which are then aligned with images from other gels and labeled. The
only valid comparison in intensity is between whole cell and sonicated sets (images treated
identically) run on the same gel.
3.2.9 Data Analysis and Interpretation—The criteria used for determining the location
of an introduced cysteine are as follows. Labeling of a cysteine residue with a membrane-
impermeable sulfhydryl reagent before disruption of whole cells is indicative of a
periplasmic cysteine residue provided accessibility to a cytoplasmically localized control
protein (see note 4) and a cysteine-less derivative of the target protein are negative (see note
8). Absence of labeling in whole cells but labeling during cell disruption indicates a
cytoplasmic location for the cysteine-containing domain. No labeling with a sulfhydryl
reagent before or during cell disruption implies localization to a hydrophobic membrane
environment or unfavorable local orientation/positioning of introduced thiol groups which
may prevent access by the reagent or result in an increase of the pKa of the thiol group as
discussed below (see note 6).
3.2.10 Topological Assignment of Problematic Regions—No definitive conclusion
can be made for the location of a domain based on lack of reaction of the cysteine (see notes
5 and 6). An unreactive cysteine can be due to its location within a TM or proximal
environmental effects, which affect the thiol pKa or sterically restrict access (6). Cysteine
scanning in the neighborhood of the unreactive cysteine may be required to differentiate
between a TM or an unreactive cysteine within a larger exposed domain. Unfavorable
orientation of a thiol group due to local secondary structure or properties of neighboring
amino acids may restrict or prevent access by large thiol reagents. Cysteine residues closer
5A major problem is the variability between samples due to mechanical loss during the work up or due to differences in expression
level of individual replacements. Since conclusions are only made by comparing sample pairs (labeling without or during cell
disruption), differences in expression or labeling efficiency between individual replacements are not important. Corrections for
mechanical loss can be made by quantitative Western blot analysis using a target specific antibody. However, if no labeling occurs
with the thiol reagent, it is important to verify that the protein was expressed and is present on the Western blot. To verify the presence
of the target protein or to ensure the presence of equal amounts of target protein in each paired sample, blots can be stripped using
RestoreTM Western Blot Stripping Buffer (Thermo Scientific) and reprobed with appropriated antibody.
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to the membrane interface generally react slower than those near the center of
extramembrane domains. Since derivatization is favored by formation of the cysteinyl
thiolate anion (Fig. 2a), increasing the reaction buffer pH would favor alkylation of an
extramembrane cysteine as well as disrupt local restrictive secondary structure while truly
membrane imbedded cysteines would not be expected react. Moreover diagnostic cysteines
can be hidden within membrane domains that partially penetrate the membrane, which have
been termed membrane-dipping, shallow-penetrating, re-entry, mini-, or U-shaped loops.
Such unusual topological arrangements are present in aquaporins, potassium chloride
channels and protein conducting channels (27). Under strongly alkaline conditions (pH >11),
soluble and peripheral membrane proteins (i.e, those that do not contain any domains that
span the membrane bilayer) are released in soluble forms. Integral membrane proteins
remain embedded in the lipid bilayer and can be isolated by centrifugation. Extramembrane
domains that are sterically hindered or exhibit elevated pKa’s can be derivatized with
increasing pH up to 10.5 without compromising membrane integrity. However, appropriate
controls such as inaccessibility of known cytoplasmically exposed domains and lack of label
of a cysteine-less target protein should be done (sse note 8). The same may apply for TMs
that form aqueous channels across or part way across the membrane. Cysteines in mini-loop
domains are exposed by NaOH with loss of membrane integrity, but a true TM remains
unreactive
To expose hindered cysteines the pH of the reaction mix is raised either step-wise to pH 10.5
in a series of reactions (see note 8). Cell integrity is maintained at pH 10.5 as evidenced by
labeling of cytosolic domains only during sonication. Cysteine-less protein and protein with
an intramembrane cysteine are not labeled at pH 10.5 (5). To detect cysteines in a mini-loop
domain, cells are treated with NaOH prior to reaction with a thiol reagent.
1. Cell aliquots in buffer A are mixed with an equal volume of cold 0.2 N NaOH,
incubated for 5 min on ice, and separated into a pellet and supernatant fraction by
centrifugation at 40,000 rpm (70,000 x g) (TLA-55 Beckman Coulter rotor) for 10
min.
2. The pellets are washed three times by suspension in Buffer A using sonication for 1
min at an amplitude of 15% followed by centrifugation as above. The final pellet is
resuspended in Buffer A and subjected to SCAMTM at pH 7.5.
3.2.10.11 Indirect and Direct Labeling and Identification of Mixed Topologies: Central
to the method is the use of detectable thiol-specific reagents to differentiate intracellular
from extracellular domains of membrane protein which in some cases may adopt mixed or
dual TM topologies within the same membrane (28) (see note 9). Confirmation of labeling
of external water-exposed cysteines by MPB can be achieved by first blocking putative
external cysteines in intact E. coli cells with a thiol-specific reagent that is transparent in the
detection phase of the procedure. Such a pre-blocking step also allows selective labeling of
luminal (exposed to cytoplasm) cysteines after cell permeabilization or disruption and
therefore detection of mixed topologies co-existing within the same cell membrane (3, 6). A
set of impermeable blocking reagents that effectively react with thiols exposed to solvent but
are transparent in the detection phase of the procedure is available for SCAMTM (6). One
such reagent is 4-acetamido-4′-maleimidylstilbene-2,2′-disulfonic acid (AMS, Fig. 3c)
which is membrane-impermeable due to its size, two charged sulfonate groups and high
solubility in water.
The degree of mixed topology can be assessed with a two-step protocol as follows. Intact
cells are treated either with or without AMS followed by labeling with MPB of intact cells
and cells during disruption. Excess AMS is removed prior to any subsequent treatments by
centrifuging the reaction mixture through a small column of gel filtration resin to avoid lysis
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of fragile cell preparations (6). In the case of mixed topology, biotinylation of the target
cysteine by MPB will occur with whole cells not pre-treated with AMS and to a greater
extent after cell disruption. AMS treatment will prevent any biotinylation with whole cells
and reduce the amount of biotinylation observed in disrupted cells. The protective effect of
AMS is almost complete and has been used to quantify the degree of mixed topology (29).
1. To confirm labeling of external (periplasmic) water-exposed cysteines by MPB and
detect possible mixed topology of LacY or protein of interest cell pellets derived
from 200 ml of mid-log phase (OD600 ~ 0.4–0.6) cells expressing a single cysteine
derivative are resuspended in 3.5 ml of buffer A and divided into four equal
aliquots (0.75 ml) in Microfuge polyallomer tubes (Beckman).
2. Two cell aliquots are incubated for 30 min at 25°C with AMS at a final
concentration of 5 mM (37.5 μl of 100 mM aqueous stock solution) to block
periplasmic water-accessible cysteine residues from the outside of cells. Then AMS
is removed either by centrifugation through a small gel filtration column or by two
cycles of centrifugation and resuspension in 0.75 ml of buffer A.
3. Two cell aliquots, one pre-treated with AMS from step 2 and one not treated with
AMS, are biotinylated by adding MPB at a final concentration of 100 μM (7.5 μl of
10 mM stock solution) followed by incubation for 5 min at 25°C and quenching of
the reaction by the addition of β-mercaptoethanol to 20 mM. Cells are then
disrupted by sonication.
4. The two remaining samples, one pre-treated with AMS from step 2 and one not
treated with AMS, are biotinylated by adding MPB at a final concentration of 100
μM (7.5 μl of 10 mM stock solution) during sonication for 1 min followed by
incubation for another 4 min at room temperature before quenching the reaction by
the addition of β-mercaptoethanol to 20 mM.
5. All samples are processed for detection of biotinylation as described above.
Acknowledgments
This work was supported by NIH grant GM20478 and funds from the John S. Dunn Foundation awarded to W. D.
References
1. Drews J. What’s in a number? Nat Rev Drug Discov. 2006; 5:975. [PubMed: 17201022]
2. Goder V, Junne T, Spiess M. Sec61p contributes to signal sequence orientation according to the
positive-inside rule. Mol Biol Cell. 2004; 15:1470–1478. [PubMed: 14668483]
3. Bogdanov M, Heacock PN, Dowhan W. A polytopic membrane protein displays a reversible
topology dependent on membrane lipid composition. EMBO J. 2002; 21:2107–2116. [PubMed:
11980707]
4. Bogdanov M, Mileykovskaya E, Dowhan W. Lipids in the Assembly of Membrane Proteins and
Organization of Protein Supercomplexes: Implications for Lipid-linked Disorders. Subcell
Biochem. 2008; 49:197–239. [PubMed: 18751913]
5. Bogdanov M, Xie J, Heacock P, Dowhan W. To flip or not to flip: lipid-protein charge interactions
are a determinant of final membrane protein topology. J Cell Biol. 2008; 182:925–935. [PubMed:
18779371]
6. Bogdanov M, Zhang W, Xie J, Dowhan W. Transmembrane protein topology mapping by the
substituted cysteine accessibility method (SCAMTM): application to lipid-specific membrane
protein topogenesis. Methods. 2005; 36:148–171. [PubMed: 15894490]
7. Wang X, Bogdanov M, Dowhan W. Topology of polytopic membrane protein subdomains is
dictated by membrane phospholipid composition. EMBO J. 2002; 21:5673–5681. [PubMed:
12411485]
Bogdanov et al. Page 13
Methods Mol Biol. Author manuscript; available in PMC 2011 May 21.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
8. Xie J, Bogdanov M, Heacock P, Dowhan W. Phosphatidylethanolamine and
monoglucosyldiacylglycerol are interchangeable in supporting topogenesis and function of the
polytopic membrane protein lactose permease. J Biol Chem. 2006; 281:19172– 19178. [PubMed:
16698795]
9. Zhang W, Bogdanov M, Pi J, Pittard AJ, Dowhan W. Reversible topological organization within a
polytopic membrane protein is governed by a change in membrane phospholipid composition. J
Biol Chem. 2003; 278:50128–50135. [PubMed: 14525982]
10. Dowhan W. Molecular Genetic Approaches to Defining Lipid Function. J Lipid Res. 2009; 50 in
press.
11. van Iwaarden PR, Pastore JC, Konings WN, Kaback HR. Construction of a functional lactose
permease devoid of cysteine residues. Biochemistry. 1991; 30:9595–9600. [PubMed: 1911745]
12. Frillingos S, Sahin-Toth M, Wu J, Kaback HR. Cys-scanning mutagenesis: a novel approach to
structure function relationships in polytopic membrane proteins. Faseb J. 1998; 12:1281–1299.
[PubMed: 9761772]
13. Elofsson A, von Heijne G. Membrane Protein Structure: Prediction vs Reality. Annu Rev
Biochem. 2007; 76:125–140. [PubMed: 17579561]
14. DeChavigny A, Heacock PN, Dowhan W. Sequence and inactivation of the pss gene of
Escherichia coli. Phosphatidylethanolamine may not be essential for cell viability. J Biol Chem.
1991; 266:5323–5332. [PubMed: 2002065]
15. Mileykovskaya E, Dowhan W. Role of membrane lipids in bacterial division site selection. Curr
Opin Microbiol. 2005; 8:135–142. [PubMed: 15802243]
16. Rietveld AG, Chupin VV, Koorengevel MC, Wienk HL, Dowhan W, de Kruijff B. Regulation of
lipid polymorphism is essential for the viability of phosphatidylethanolamine-deficient Escherichia
coli cells. J Biol Chem. 1994; 269:28670– 28675. [PubMed: 7961817]
17. Wikström M, Xie J, Bogdanov M, Mileykovskaya E, Heacock P, Wieslander Å, Dowhan W.
Monoglucosyldiacylglycerol, a foreign lipid, can substitute for phosphatidylethanolamine in
essential membrane-associated functions in Escherichia coli. J Biol Chem. 2004; 279:10484–
10493. [PubMed: 14688287]
18. Wikström M, Kelly A, Georgiev A, Eriksson H, Rosen-Klement M, Bogdanov M, Dowhan W,
Wieslander Å. Lipid-engineered Escherichia coli membranes reveal critical lipid head-group size
for protein function. J Biol Chem. 2009:284. [PubMed: 18984583]
19. Zhang W, Campbell HA, King SC, Dowhan W. Phospholipids as determinants of membrane
protein topology. Phosphatidylethanolamine is required for the proper topological organization of
the gamma-aminobutyric acid permease (GabP) of Escherichia coli. J Biol Chem. 2005;
280:26032–26038. [PubMed: 15890647]
20. Sato Y, Zhang YW, AAT, Rudnick G. Analysis of transmembrane domain 2 of rat serotonin
transporter by cysteine scanning mutagenesis. J Biol Chem. 2004; 279:22926–22933. [PubMed:
15044496]
21. Wada T, Long JC, Zhang D, Vik SB. A novel labeling approach supports the five-transmembrane
model of subunit a of the Escherichia coli ATP synthase. J Biol Chem. 1999; 274:17353–17357.
[PubMed: 10358096]
22. Cao W, Matherly LH. Characterization of a cysteine-less human reduced folate carrier: localization
of a substrate-binding domain by cysteine-scanning mutagenesis and cysteine accessibility
methods. Biochem J. 2003; 374:27–36. [PubMed: 12749765]
23. Zhu Q, Lee DW, Casey JR. Novel topology in C-terminal region of the human plasma membrane
anion exchanger, AE1. J Biol Chem. 2003; 278:3112–3120. [PubMed: 12446737]
24. Fujihira E, Tamura N, Yamaguchi A. Membrane topology of a multidrug efflux transporter, AcrB,
in Escherichia coli. J Biochem. 2002; 131:145–151. [PubMed: 11754746]
25. Long JC, DeLeon-Rangel J, Vik SB. Characterization of the first cytoplasmic loop of subunit a of
the Escherichia coli ATP synthase by surface labeling, cross-linking, and mutagenesis. J Biol
Chem. 2002; 277:27288–27293. [PubMed: 12021273]
26. Valiyaveetil FI, Fillingame RH. Transmembrane topography of subunit a in the Escherichia coli
F1F0 ATP synthase. J Biol Chem. 1998; 273:16241–16247. [PubMed: 9632683]
Bogdanov et al. Page 14
Methods Mol Biol. Author manuscript; available in PMC 2011 May 21.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
27. Lasso G, Antoniw JF, Mullins GL. A combinatorial pattern discovery approach for the prediction
of membrane dipping (re-entrant) loops. Bioinformatics. 2006; 22:290–297.
28. Gafvelin G, von Heijne G. Topological “frustration” in multispanning E. coli inner membrane
proteins. Cell. 1994; 77:401–412. [PubMed: 8181060]
29. Kimura T, Ohnuma M, Sawai T, Yamaguchi A. Membrane topology of the transposon 10-encoded
metal-tetracycline/H+ antiporter as studied by site-directed chemical labeling. J Biol Chem. 1997;
272:580–585. [PubMed: 8995300]
30. Martinez-Morales F, Schobert M, Lopez-Lara IM, Geiger O. Pathways for phosphatidylcholine
biosynthesis in bacteria. Microbiology. 2003; 149:3461–3471. [PubMed: 14663079]
31. Shiba Y, Yokoyama Y, Aono Y, Kiuchi T, Kusaka J, Matsumoto K, Hara H. Activation of the Rcs
signal transduction system is responsible for the thermosensitive growth defect of an Escherichia
coli mutant lacking phosphatidylglycerol and cardiolipin. J Bacteriol. 2004; 186:6526–6535.
[PubMed: 15375134]
Bogdanov et al. Page 15
Methods Mol Biol. Author manuscript; available in PMC 2011 May 21.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig. 1.
Lipid profiles of E. coli mutants with altered lipid compositions. (a) Lane 1. AL95
(pss93::kanR lacY::Tn9)/pDD72 (pssA+ camr) has wild type phospholipid composition (80
mole % PE and 20 mole % PG plus CL) due to complementation by a plasmid (pDD72)
copy of the null allele of the pssA gene that encodes the committed step to PE biosynthesis
(3). Lane 2. AL95 (pss93::kanR lacY::Tn9) is PE-lacking due to the a null allele of the pssA
gene and contains mainly CL and PG (3). Lane 3. Introduction of plasmid pTMG3 (ALmgs
ampR) into strain AL95 results in 35 mole % monoglucosyldiacylglycerol (MGlcDAG) due
to the expression of the A. laidlawii MGlcDAG synthase gene. The remaining lipids are
primarily PG (35 mole %) and CL (25 mole%) (8). Lane 4. Introduction into AL95 of the
genes from A. laidlawii that synthesize MGlcDAG and diglucosyldiacylglycerol
(DGlcDAG) results in about 30–40 mole % DGlcDAG with less than 1 mole % MGlcDAG
(18). Lane 5. Introduction of the pcs gene (placed under OParaB regulatory control) from
Legionella pneumophila (30) that confers the ability to synthesize PC results in about 70
mole % PC with the remainder being PG (2.5 mole %) plus CL (26 mole %) and other minor
lipids (P. N. Heacock and W. Dowhan, unpublished). Lane 6. UE54 (pgsA::FRT-kan-FRT
lpp-2 Δara714 rcsF::mini-Tn10cam) carries a null allele of the pgsA gene encoding the
committed step to PG and CL biosynthesis making it devoid of PG and CL and containing
about 90 mole % PE, 4.0 mole % phosphatidic acid (PA) and 3.2% CDP-diacylglycerol.
Figure and compositional results taken from (31). (b) Phospholipid composition as a
function of pssA gene induction. Strain AT2033 was grown first in the absence of aTc (time
0) followed by growth in the presence of aTc for 3 h. When grown without aTc, AT2033 has
a greatly reduced level of PE and contains elevated levels of PG and CL. Growth in the
presence of aTc results a progressive increase in PE to normal levels (5). Lipid composition
is shown as mole % of the total major phospholipid species.
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Fig. 2. Structure of thiol-modifying reagents and their reaction with a thiol
(a) Reaction of a maleimide with the thiolate of a protein bound cysteine to form a covalent
adduct. (b) Structure of MPB. (c) Structure of AMS. Figure reproduced from (6) with
permission.
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Fig. 3.
Schematic illustration of the Western blotting sandwich used with a semi-dry electroblotting
system.
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